LONDON, May 9 /PRNewswire/ --

- Statement

The Royal Pharmaceutical Society of Great Britain (RPSGB) today called for the Government to undertake impact assessments in its planning of polyclinics.

Director of Practice Quality and Improvement at the RPSGB, David Pruce said:

"Pharmacists in England are keen to play a larger role in healthcare provision for the future and the RPSGB believes this is vital to ensure that patients, the public and particularly those classed as vulnerable are able to choose the healthcare services they need.

"For that reason we are calling for guaranteed impact assessments to be carried out in every locality where there are plans to introduce polyclinics."

An international study has discovered 10 new genes related to human growth.

This meta-analysis, published in the latest issue of Nature Genetics, is based on data from more than 26,000 study participants. It verifies two already known genes, but also discovered ten new genes. Altogether they explain a difference in body size of about 3.5 centimeters.

The analysis produced some biologically insightful findings. Several of the identified genes are targeted by the microRNA let-7, which affects the regulation of other genes. This connection was completely unknown until now. Several other SNPs may affect the structure of chromatin, the chromosome-surrounding proteins. Moreover, the results could have relevance for patients with inherited growth problems, or with problems in bone development, because some of the newly discovered genes have rare mutations, known to be associated with anomalous skeletal growth. Further functional studies are necessary to completely elucidate the biological mechanisms behind this growing list of genes related to height.

ST. DAVID'S, Bermuda, May 9 /PRNewswire/ --

- Growth of promoted products and reduced operating costs drive solid earnings growth.

Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2008. Revenue in the quarter ended March 31, 2008 totaled US$229.5 million, an increase of 5.1%, over the prior year quarter. The primary drivers of the increase in revenue were the net sales of our promoted products LOESTRIN 24 FE, DORYX, TACLONEX and FEMCON FE, which together contributed US$34.4 million of revenue growth for the quarter ended March 31, 2008 compared to the prior year quarter. The growth delivered by these products was offset primarily by a significant decline in ESTROSTEP FE revenue due to generic competition.

A protein that is indispensable for passing on an accurate copy of the genome from mother to daughter cells can be compared to a cowboy’s lasso, say scientists at the The FIRC Institute of Molecular Oncology Foundation (IFOM).

It 'catches' chromosomes and ties them to a transitory structure assembled during cell division. Once they have been neatly tied up, the chromosomes await the end of replication to be equally distributed between the two daughter cells. But if the lasso doesn’t catch them, chromosomes end up being randomly scattered, with potentially disastrous genetic effects: should cells survive this, they receive the wrong genetic inheritance, with dire consequences.

This study opens up new avenues of research to reduce the toxicity of chemotherapy in the treatment of cancer.

WOKING, England, May 9 /PRNewswire/ --

- UK Based Risk Management Company Pilgrims Group Ltd has Been Praised by the US Army for its Work in Iraq.

Working for a leading communications equipment manufacturer, communications experts Pilgrims Group Ltd was enlisted to provide a team of communication and technical specialists to train the US Army in using specialist communications systems and provide maintenance and installation support, often in extreme conditions.

NEW YORK, May 9 /PRNewswire/ --

- Third Annual Event Features Deployment, Emerging and Multi-Protocol Application Categories

Liberty Alliance, the global identity community working to build a more trust-worthy internet for consumers, governments and businesses worldwide, today announced a call for nominations for the 2008 IDDY Awards. The IDDY Award (IDentity Deployment of the Year) recognizes identity-based applications built using Liberty Federation (SAML 2.0), Liberty Web Services, Liberty People Service and Liberty Advanced Client specifications. The call for nominations ends on Monday, June 16, with winners announced on June 30. IDDY Awards will be presented at CSO magazine's Digital ID World 2008 conference (September 8-10) in Anaheim, CA.

DUBLIN, Ireland and WASHINGTON, May 9 /PRNewswire/ --

dotMobi -- the company behind the .mobi internet domain name for mobile phones and the dev.mobi developer forum -- today announced it has acquired the intellectual property assets of Mowser, a San Mateo, Calif.-based mobile browsing company.

Financial terms of the deal were not disclosed.

dotMobi's acquisition of Mowser's technology, developed by Bay Area mobile pioneers Russell Beattie and Michael Rowehl, is another way for dotMobi to provide a complete range of mobile content creation solutions for businesses of all sizes.

CLEVELAND, Illinois and ROTTERDAM, The Netherlands, May 9 /PRNewswire/ -- University Hospitals Case Medical Center and Cardialysis BV today announced that the Companies have the intention to found Cardialysis Cleveland to provide combined clinical drug development and medical imaging services to clients that are developing therapeutics or medical devices for cardiovascular indications in world wide studies.

NEWCASTLE-GATESHEAD, England, May 9 /PRNewswire/ --

- Kurzweil, Greg Dyke, 'Fake Steve Jobs', Multimap Founder & More to Speak

Some of the sharpest minds in technology, digital marketing and mobile will head to North East England from around the world later on 21-23 May to discuss the ideas and technologies that are set to fundamentally alter the way people live and work.

HOUSTON, May 9 /PRNewswire/ --

Endeavour International Corporation (Amex: END) (LSE: ENDV) today announced that the company will be one of the presenting companies at Tristone Capital's global energy conference to be held May 12 - 16, 2008 in Paris, France.

William Transier, chairman, chief executive officer and president is scheduled to speak on the company's business strategies and operational plans at 2:20 p.m. Paris, 1:20 p.m. London, and 7:20 a.m. Houston on Thursday, May 15, 2008. The link to the live webcast and the replay will be available on the home page of the company's website at http://www.endeavourcorp.com.